Prof Tom Gonda
Professor Tom Gonda
SENIOR ASSOCIATE
Prof Tom Gonda
• Professor, Centre for Cancer Biology, University of South Australia (part-time)
• Honorary Professor, University of Queensland (since 2016)
• Consultant in biomedical research
• Internationally-known cancer researcher with expertise in leukaemia, breast cancer, transcription, oncogenes, experimental haematology, functional and cancer genomics.
• Experience with small-molecule drug discovery and development
• Over 140 publications with a total of >14,000 citations, H-index 58
• Member (2007-15) and Deputy Chair (2014-15), University of Queensland Institutional Biosafety Subcommittee
• Extensive experience in pre-submission grant reviews and grant assessment; member of multiple NHMRC GRPs (2000-2019) and ARC College of Experts (2003-6). Review of funding applications for over 30 agencies.
• Peer reviews for over 30 journals including Nature Genetics, Blood, Cancer Cell, Cancer Discovery, EMBO Journal, Proc Natl Acad Sci (USA).
• Co-Founder, New Directions in Leukaemia Research conference series (biennial since 2006)
• Industry experience: Chief Scientist, Bionomics Ltd (2001-3); research interactions with Progen Ltd, Novartis, GSK
• Head, Cancer Biology Program, UQ Diamantina Institute (2004-8)
• Deputy Director, UQ Diamantina Institute (2006-8)
• NHMRC Research Fellow (1990-2001); UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant (1998); American Cancer Society (California Division) Postdoctoral Fellowship (1980-1981)
• Member, National Breast Cancer Foundation Expert Group on Strategic Planning (2003)
• External Expert Member, Review Panel for the Ramaciotti Centre for Gene Function Analysis, UNSW (2012)